Use of Platelet Rich Plasma After Arthroscopic Debridement for Triangular Fibrocartilage Complex Tears

Stopped early · Not applicable

Conditions studied: Arthroscopic Surgery, Triangular Fibrocartilage Complex Injury

In brief

The objective of this study is to compare outcomes and functionality measures of subjects treated with platelet rich plasma (PRP) after arthroscopic debridement of triangular fibrocartilage complex (TFCC) tears to subjects treated with arthroscopic debridement alone.

Key facts

Study ID
NCT03805698
Run by
Cedars-Sinai Medical Center
People needed
10
Starts
2019-01-03
Expected to finish
2021-02-06
Last updated by the study team
2022-10-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.